Kathleen A. Rickard sold $1.2M of Verona Pharma (VRNA)

Executed Nov 25 2024, disclosed Nov 26 2024, 1 day later.

Value, as filed

$1.2M

240,000 sh × $4.90

Executed

Nov 25 2024

the trade date, as filed

Disclosed

Nov 26 2024

1 day after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

KR Kathleen A. Rickard Chief Medical Officer profile →

Kathleen A. Rickard (Chief Medical Officer) filed 6 Form 4 reports in the past 24 months (0 purchases, 6 sales), most often in VRNA. The largest single filing was $1.2M of VRNA (240,000 sh × $4.90, as filed), executed Nov 25 2024.

The name

VRNA VRNA VRNA · 40 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Kathleen A. Rickard in VRNA

VRNASALE Verona Pharma plc $767K
58,336 sh × $13.14
Exec Aug 1 2025
Filed Aug 5 2025 · 5:30 PM ET VRNASALE Verona Pharma plc $1.0M
114,984 sh × $8.82
Exec May 6 2025
Filed May 8 2025 · 5:30 PM ET VRNASALE Verona Pharma plc $440K
49,200 sh across 2 lots
Exec May 1 2025
Filed May 5 2025 · 5:30 PM ET VRNASALE Verona Pharma plc $309K
34,384 sh × $8.98
Exec Apr 29 2025
Filed May 1 2025 · 5:30 PM ET VRNASALE Verona Pharma plc $662K
79,264 sh × $8.35
Exec Mar 12 2025
Filed Mar 13 2025 · 5:30 PM ET